Recombinant Human Thymosin β4 (rhTβ4) Modulates the Anti-Inflammatory Responses to Alleviate Benzalkonium Chloride (BAC)-Induced Dry Eye Disease.

Int J Mol Sci · 2022 · PMC9141377 · PMID 35628276

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Healing of Dry Eye with rhTβ4 Treatments in Mice Tear volumes after 7 days were tested and both 0.05% and 0.1% Tβ4 groups showed a trend of improvement compared with the BAC group ( Figure 1 A).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.